Literature DB >> 22047200

Type of steatosis influences microcirculation and fibrogenesis in different rat strains.

Stephan Rosenstengel1, Sandra Stoeppeler, Ralf Bahde, Hans-Ullrich Spiegel, Daniel Palmes.   

Abstract

This study investigates the impact of rat strain on the development of nonalcoholic fatty liver disease (NAFLD) focusing on morphological features and microcirculation. Male rats of Lewis, Wistar, and Sprague Dawley (n = 6 per strain and group) were randomized into a high-fat group which was fed with a special high-fat nutrition for a 3-week period and a control group which received standard nutrition. Intravital microscopy was used for the evaluation of microcirculation and correlated to morphological changes using a fatty liver scoring system. All three strains receiving a high-fat diet developed a grade 3 steatosis (>66% liver cell steatosis). Whereas Lewis showed a solely microvesicular steatosis, Wistar developed a mixed form and Sprague Dawley showed a pure macrovesicular steatosis and the highest degree of fibrosis and hepatocyte damage. Microcirculatory results revealed that sinusoidal density was already affected by a microvesicular steatosis and decreased with increasing macrovesicular proportion (Lewis: 18%, Wistar: 31%, Sprague Dawley: 23%). The degree of steatosis correlates with reduced blood flow velocity in central veins as well as in sinusoids (Lewis: 28%, Wistar: 39%, Sprague Dawley 44%). The densities of hepatocytes and hepatic stellate cells were only impaired once macrovesicular cell steatosis (Wistar and Sprague Dawley) was present. The development of NAFLD in the rat revealed strain-specific morphological features correlating with microcirculatory changes that should be considered in further studies using these models.

Entities:  

Mesh:

Year:  2011        PMID: 22047200     DOI: 10.3109/08941939.2011.586094

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  12 in total

1.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Lipid metabolism in adipose tissue and liver from diet-induced obese rats: a comparison between Wistar and Sprague-Dawley strains.

Authors:  Jonatan Miranda; Itziar Eseberri; Arrate Lasa; María P Portillo
Journal:  J Physiol Biochem       Date:  2018-11-09       Impact factor: 4.158

3.  Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.

Authors:  Marie Liebig; Alireza Hassanzada; Malte Kämmerling; Berit Genz; Brigitte Vollmar; Kerstin Abshagen
Journal:  Exp Biol Med (Maywood)       Date:  2017-10-24

Review 4.  From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations.

Authors:  Charlotte J Green; Camilla Pramfalk; Karl J Morten; Leanne Hodson
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-28       Impact factor: 4.310

Review 5.  Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers.

Authors:  Sarit Anavi; Zecharia Madar; Oren Tirosh
Journal:  Redox Biol       Date:  2017-06-22       Impact factor: 11.799

6.  Using liquid chromatography mass spectrometry (LC-MS) to assess the effect of age, high-fat diet, and rat strain on the liver metabolome.

Authors:  Greg Boyce; Mohammad Shoeb; Vamsi Kodali; Terence Meighan; Jenny R Roberts; Aaron Erdely; Michael Kashon; James M Antonini
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

7.  The Propensity of the Human Liver to Form Large Lipid Droplets Is Associated with PNPLA3 Polymorphism, Reduced INSIG1 and NPC1L1 Expression and Increased Fibrogenetic Capacity.

Authors:  Flaminia Ferri; Simone Carotti; Guido Carpino; Monica Mischitelli; Alfredo Cantafora; Antonio Molinaro; Maria Eva Argenziano; Simona Parisse; Alessandro Corsi; Mara Riminucci; Quirino Lai; Gianluca Mennini; Gustavo Spadetta; Francesco Pugliese; Massimo Rossi; Sergio Morini; Eugenio Gaudio; Stefano Ginanni Corradini
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

8.  Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution.

Authors:  Yuichi Nozaki; Koji Fujita; Koichiro Wada; Masato Yoneda; Yoshiyasu Shinohara; Kento Imajo; Yuji Ogawa; Takaomi Kessoku; Makoto Nakamuta; Satoru Saito; Naohiko Masaki; Yoji Nagashima; Yasuo Terauchi; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2015-12-17       Impact factor: 3.067

9.  INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis.

Authors:  Jonathan D Roth; Michael Feigh; Sanne S Veidal; Louise Kd Fensholdt; Kristoffer T Rigbolt; Henrik H Hansen; Li C Chen; Mathieu Petitjean; Weslyn Friley; Niels Vrang; Jacob Jelsing; Mark Young
Journal:  World J Gastroenterol       Date:  2018-01-14       Impact factor: 5.742

10.  Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress.

Authors:  Evelyn Nunes Goulart da Silva Pereira; Beatriz Peres de Araujo; Karine Lino Rodrigues; Raquel Rangel Silvares; Carolina Souza Machado Martins; Edgar Eduardo Ilaquita Flores; Caroline Fernandes-Santos; Anissa Daliry
Journal:  Nutrients       Date:  2022-02-08       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.